Retirement Systems of Alabama Sells 2,034 Shares of Encompass Health Co. (NYSE:EHC)

Retirement Systems of Alabama cut its position in shares of Encompass Health Co. (NYSE:EHC) by 0.7% in the third quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 275,536 shares of the company’s stock after selling 2,034 shares during the period. Retirement Systems of Alabama owned approximately 0.27% of Encompass Health worth $26,628,000 at the end of the most recent quarter.

Several other hedge funds also recently added to or reduced their stakes in the company. Franklin Resources Inc. boosted its position in shares of Encompass Health by 22.0% during the third quarter. Franklin Resources Inc. now owns 700,021 shares of the company’s stock valued at $67,412,000 after buying an additional 126,000 shares during the period. Synovus Financial Corp boosted its holdings in Encompass Health by 92.9% during the 3rd quarter. Synovus Financial Corp now owns 16,057 shares of the company’s stock valued at $1,552,000 after acquiring an additional 7,733 shares during the period. Tidal Investments LLC grew its position in Encompass Health by 5.7% in the 3rd quarter. Tidal Investments LLC now owns 3,509 shares of the company’s stock valued at $339,000 after acquiring an additional 188 shares during the last quarter. TD Private Client Wealth LLC increased its stake in Encompass Health by 2,870.0% in the third quarter. TD Private Client Wealth LLC now owns 7,336 shares of the company’s stock worth $709,000 after purchasing an additional 7,089 shares during the period. Finally, Coldstream Capital Management Inc. lifted its position in shares of Encompass Health by 4.1% during the third quarter. Coldstream Capital Management Inc. now owns 27,636 shares of the company’s stock worth $2,672,000 after purchasing an additional 1,088 shares during the last quarter. 97.25% of the stock is currently owned by institutional investors.

Encompass Health Trading Down 0.5 %

Shares of NYSE EHC opened at $98.19 on Friday. The business has a fifty day moving average price of $99.35 and a 200 day moving average price of $92.49. Encompass Health Co. has a 1-year low of $65.33 and a 1-year high of $104.55. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 1.04. The stock has a market capitalization of $9.89 billion, a P/E ratio of 23.72, a price-to-earnings-growth ratio of 1.34 and a beta of 0.86.

Encompass Health (NYSE:EHC) last released its quarterly earnings results on Monday, October 28th. The company reported $1.03 earnings per share for the quarter, beating analysts’ consensus estimates of $0.94 by $0.09. The business had revenue of $1.35 billion for the quarter, compared to analysts’ expectations of $1.33 billion. Encompass Health had a net margin of 8.10% and a return on equity of 17.60%. The company’s revenue was up 11.9% compared to the same quarter last year. During the same period last year, the business earned $0.86 EPS. Equities research analysts expect that Encompass Health Co. will post 4.29 EPS for the current fiscal year.

Encompass Health Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 15th. Stockholders of record on Thursday, January 2nd will be issued a dividend of $0.17 per share. The ex-dividend date is Thursday, January 2nd. This represents a $0.68 annualized dividend and a dividend yield of 0.69%. Encompass Health’s dividend payout ratio is presently 16.43%.

Wall Street Analyst Weigh In

A number of research analysts have recently commented on EHC shares. UBS Group upped their price target on shares of Encompass Health from $100.00 to $110.00 and gave the stock a “buy” rating in a report on Wednesday, September 25th. Barclays raised their target price on shares of Encompass Health from $109.00 to $116.00 and gave the stock an “overweight” rating in a research report on Tuesday, October 29th. Truist Financial reiterated a “buy” rating and issued a $116.00 price target (up previously from $108.00) on shares of Encompass Health in a report on Wednesday, October 30th. KeyCorp raised their price objective on Encompass Health from $115.00 to $117.00 and gave the stock an “overweight” rating in a report on Tuesday, October 29th. Finally, Royal Bank of Canada upped their target price on Encompass Health from $105.00 to $110.00 and gave the stock an “outperform” rating in a report on Wednesday, October 30th. Nine investment analysts have rated the stock with a buy rating and two have assigned a strong buy rating to the stock. Based on data from MarketBeat, the stock presently has an average rating of “Buy” and a consensus price target of $107.11.

About Encompass Health

Encompass Health Corporation provides post-acute healthcare services in the United States and Puerto Rico. It owns and operates inpatient rehabilitation hospitals that provide medical, nursing, therapy, and ancillary services. The company provides specialized rehabilitative treatment on an inpatient basis to patients who have experienced physical or cognitive disabilities or injuries due to medical conditions, such as strokes, hip fractures, and various debilitating neurological conditions.